A specific monosialoganglioside that accumulates abnormally within the nervous system due to a deficiency of GM1-b-galactosidase, resulting in GM1 gangliosidosis.
G M1 Ganglioside has been studied across 16 research domains including 🔥 Metabolic, 🔬 Oncology, 🧠 Neuroprotection, 🫁 Liver & Detox, 🛡️ Immunity. The primary research focus is 🔥 Metabolic with 19% of studies addressing this area.
This evidence profile for G M1 Ganglioside is generated deterministically from 59 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.